author-photo

Audrey L. Shaw

Salix Pharmaceuticals

35

Papers

1774

Citations

Citation Trend

Filter By

Papers (25) Sort By

Journal Conference Others

Retrospective Chart Review Study of Patients Receiving Serum-Derived Bovine Immunoglobulin/Protein Isolate (SBI) for Nutritional Management of Irritable Bowel Syndrome with Diarrhea (IBS-D): 2451

2016 The American Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
Endotoxin neutralization activity (ENA) of bovine plasma and bovine Immunoglobulin (IgG)‐rich fractions as compared to human plasma

2013 The FASEB Journal
Show All
- Source
- Cite
- Save
Citations (9)
Méthodes de traitement de l'encéphalopathie hépatique

2011
Show All
- Source
- Cite
- Save
Citations (0)
Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

2011 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (741)
Rifaximin Treatment in Hepatic Encephalopathy

2010 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (839)
15 RIFAXIMIN TREATMENT IMPROVED QUALITY OF LIFE IN PATIENTS WITH HEPATIC ENCEPHALOPATHY: RESULTS OF A LARGE, RANDOMIZED, PLACEBO-CONTROLLED TRIAL

2010 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (8)
Rifaximin Treatment Consistently Demonstrated Relief Across Daily Symptoms in Patients with Non-Constipation Irritable Bowel Syndrome: Results from 2 Phase 3 Trials (TARGET 1 and TARGET 2): 1312

2010 The American Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
475i Rifaximin Treatment for 2 Weeks Provides Acute and Sustained Relief Over 12 Weeks of IBS Symptoms in Non-Constipated Irritable Bowel Syndrome: Results From 2 North American Phase 3 Trials (Target 1 and Target 2)

2010 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (12)
The Responsiveness and Validity of a Binary Weekly Recall Question and the Proposed FDA Composite Endpoint as Measures of Daily Symptom Severity in Non-Constipation Irritable Bowel Syndrome: Results of TARGET 1 and TARGET 2: 1337

2010 The American Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
93 RIFAXIMIN IS EFFECTIVE IN MAINTAINING REMISSION IN HEPATIC ENCEPHALOPATHY: RESULTS OF A LARGE, RANDOMIZED, PLACEBO-CONTROLLED TRIAL

2009 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (11)